The Central Drugs Standard Control Organization (CDSCO) has given approval for an indigenous Mpox test kit, marking a significant step forward in India’s healthcare sector. The domestically developed kit is designed to diagnose Mpox, a viral infection, more efficiently and accurately.
This approval is expected to enhance the nation’s ability to detect and respond to Mpox outbreaks promptly. The new test kit will enable faster identification of cases, which is crucial for containing the spread of the virus.
The indigenous development of the kit underscores India’s growing capabilities in medical research and innovation, reducing reliance on imported technologies while boosting the local biotech industry. This approval is seen as a positive move towards strengthening the country’s preparedness in managing viral diseases.
